JP2021526123A5 - - Google Patents

Info

Publication number
JP2021526123A5
JP2021526123A5 JP2020540731A JP2020540731A JP2021526123A5 JP 2021526123 A5 JP2021526123 A5 JP 2021526123A5 JP 2020540731 A JP2020540731 A JP 2020540731A JP 2020540731 A JP2020540731 A JP 2020540731A JP 2021526123 A5 JP2021526123 A5 JP 2021526123A5
Authority
JP
Japan
Prior art keywords
alkyl
heterocycloalkyl
cycloalkyl
heteroaryl
aryl
Prior art date
Application number
JP2020540731A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021526123A (ja
JPWO2019228403A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2019/089025 external-priority patent/WO2019228403A1/en
Publication of JP2021526123A publication Critical patent/JP2021526123A/ja
Publication of JP2021526123A5 publication Critical patent/JP2021526123A5/ja
Publication of JPWO2019228403A5 publication Critical patent/JPWO2019228403A5/ja
Pending legal-status Critical Current

Links

JP2020540731A 2018-05-29 2019-05-29 オートタキシン阻害剤とその使用 Pending JP2021526123A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862677459P 2018-05-29 2018-05-29
US62/677,459 2018-05-29
US201862731003P 2018-09-13 2018-09-13
US62/731,003 2018-09-13
PCT/CN2019/089025 WO2019228403A1 (en) 2018-05-29 2019-05-29 Autotaxin inhibitors and uses thereof

Publications (3)

Publication Number Publication Date
JP2021526123A JP2021526123A (ja) 2021-09-30
JP2021526123A5 true JP2021526123A5 (https=) 2022-05-27
JPWO2019228403A5 JPWO2019228403A5 (https=) 2022-05-27

Family

ID=68697812

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020540731A Pending JP2021526123A (ja) 2018-05-29 2019-05-29 オートタキシン阻害剤とその使用

Country Status (5)

Country Link
EP (1) EP3728257A4 (https=)
JP (1) JP2021526123A (https=)
CN (1) CN111801328B (https=)
CA (1) CA3089527A1 (https=)
WO (1) WO2019228403A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11591342B2 (en) * 2018-02-14 2023-02-28 Suzhou Sinovent Pharmaceuticals Co., Ltd. Heterocyclic compound, application thereof and pharmaceutical composition comprising same
CN113912600A (zh) * 2020-07-09 2022-01-11 苏州爱科百发生物医药技术有限公司 一种atx抑制剂及其制备方法和应用
CN115916777B (zh) * 2020-07-09 2024-07-12 苏州爱科百发生物医药技术有限公司 一种atx抑制剂及其制备方法和应用
JP2023536159A (ja) * 2020-07-31 2023-08-23 ジェネンテック, インコーポレイテッド 炎症性呼吸器疾患の増悪を治療するための方法
CN114315825A (zh) * 2020-09-30 2022-04-12 江西济民可信集团有限公司 吡啶并咪唑衍生物及其制备方法和应用
EP4225756A2 (en) 2020-10-06 2023-08-16 Ildong Pharmaceutical Co., Ltd. Autotaxin inhibitor compounds
US20240317736A1 (en) * 2020-11-04 2024-09-26 Xizang Haisco Pharmaceutical Co., Ltd. Deuterated derivative as atx inhibitor, and application thereof
CN112675308B (zh) * 2020-12-09 2023-05-05 中国人民解放军军事科学院军事医学研究院 抑制enpp2基因和/或蛋白表达的物质在制备治疗多发性骨髓瘤的药物中的应用
US20240327407A1 (en) 2021-01-05 2024-10-03 Cadila Heal Thcare Limited Novel inhibitors of autotaxin
EP4323356A1 (en) 2021-04-13 2024-02-21 Nuvalent, Inc. Amino-substituted heterocycles for treating cancers with egfr mutations
TW202342138A (zh) * 2022-03-31 2023-11-01 大陸商蘇州愛科百發生物醫藥技術有限公司 Atx抑制劑或其鹽的結晶形式及其制備方法與應用
JP2025525350A (ja) * 2022-06-24 2025-08-05 エフ. ホフマン-ラ ロシュ アーゲー Magl阻害剤としての新規複素環-カルボニル-環式化合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2970255T1 (sl) * 2013-03-14 2017-12-29 Galapagos Nv Spojine in farmacevtski sestavki le-teh za zdravljenje vnetnih motenj
EP3010922B1 (en) * 2013-06-19 2017-03-15 Galapagos NV Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
TW201908293A (zh) * 2017-07-12 2019-03-01 美商必治妥美雅史谷比公司 作為rock抑制劑之5員及雙環雜環醯胺
US11591342B2 (en) * 2018-02-14 2023-02-28 Suzhou Sinovent Pharmaceuticals Co., Ltd. Heterocyclic compound, application thereof and pharmaceutical composition comprising same

Similar Documents

Publication Publication Date Title
JP2021526123A5 (https=)
AU2017382405B2 (en) Compositions and methods for inhibiting arginase activity
CN107417691B (zh) 高效的抗赘生剂和抗增生剂
JP2021534124A5 (https=)
JP2014528433A5 (https=)
US20080182845A1 (en) Method of preventing or treating organ, hematopoietic stem cell or bone marrow transplant rejection
RU2014105624A (ru) Соединения индазола, способ их применения и фармацевтическая композиция
JP2006507265A5 (https=)
JP2021527638A5 (https=)
JP2008526999A5 (https=)
JP2022141692A5 (https=)
JP2013529196A5 (https=)
JP2011530500A5 (https=)
RU2009117642A (ru) Применение спирооксиндоловых соединений в качестве терапевтических средств
JP2003535094A5 (https=)
AR041055A1 (es) Derivados de benzoimidazol utiles como agentes antiproliferativos, composicion farmaceautica en base al compuesto y un procedimiento de preparacion del compuesto
JP2021523200A5 (https=)
AR046297A1 (es) Inhibidores de la dpp - iv metodos para prepararlos y composiciones farmaceuticas que los contienen como agente activo
RU2016118768A (ru) Композиции, пригодные для лечения расстройств, связанных с kit
AR039570A1 (es) Antagonistas de los receptores de trombina
JP2016506959A5 (https=)
RU2009120229A (ru) Производные хинуклидинола в качестве антагонистов мускариновых рецепторов
JP2016513681A5 (https=)
RU2005105337A (ru) Противомикробные хинолины, их композиции и применение
JP2011517453A5 (https=)